Company Name: Zafgen, Inc.
Zafgen, Inc. is a biopharmaceutical company. The company’s focus is on obesity and complex metabolic disorders. The company’s lead product candidate is an obesity therapy with applications in several areas including hypothalamic injury-associated obesity (HIAO), Prader-Willi syndrome (PWS) and severe obesity.
Ticker Symbol: ZFGN (NASDAQ)
Company Website: www.zafgen.com
Headquarters: Boston, MA